ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 10 (2) 141 -152     DOI: 10.1677/erc.0.0100141
Copyright © 2003 by the Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menendez, J.
Right arrow Articles by Lupu, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menendez, J.
Right arrow Articles by Lupu, R
Endocrine Related Cancer, Vol 10, Issue 2, 141-152
Copyright © 2003 by Society for Endocrinology


Articles

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives

JA Menendez, I Mehmi, DW Griggs, and R Lupu


CYR61 (CNN1), a member of the cysteine rich 61/connective tissue growth factor/nephroblastoma overexpressed (CYR61/CTFG/NOV) family of growth regulators (CNN), is a pro-angiogenic factor that mediates diverse roles in development, cell proliferation, and tumorigenesis. We have recently shown that CYR61 is overexpressed in invasive and metastatic human breast cancer cells. Accordingly, elevated levels of CYR61 in breast cancer are associated with more advanced disease. Unfortunately, the exact mechanisms by which CYR61 promotes an aggressive breast cancer phenotype are still largely unknown. This review examines the functional role of CYR61 in breast cancer disease, presenting evidence that CYR61 signaling may play a major role in estrogen- as well as growth factor-dependent breast cancer progression. We also emphasize the functional significance of the molecular connection of CYR61 and its integrin receptor alpha(v)beta(3) enhancing breast cancer aggressiveness. Moreover, we describe experimental evidence that establishes a novel role for CYR61 determining the protection of human breast cancer cells against chemotherapy-induced apoptosis through its interactions with the integrin receptor alpha(v)beta(3). All these findings delineate a new noteworthy function of a CYR61/alpha(v)beta(3) autocrine-paracrine signaling pathway within both angiogenesis and breast cancer progression, which would allow a dual anti-angiogenic and anti-tumor benefit with a single drug.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. S. Dobroff, H. Wang, V. O. Melnikova, G. J. Villares, M. Zigler, L. Huang, and M. Bar-Eli
Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma
J. Biol. Chem., September 18, 2009; 284(38): 26194 - 26206.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. A. Franzen, C.-C. Chen, V. Todorovic, V. Juric, R. I. Monzon, and L. F. Lau
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
Mol. Cancer Res., July 1, 2009; 7(7): 1045 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Bonuccelli, M. C. Casimiro, F. Sotgia, C. Wang, M. Liu, S. Katiyar, J. Zhou, E. Dew, F. Capozza, K. M. Daumer, et al.
Caveolin-1 (P132L), a Common Breast Cancer Mutation, Confers Mammary Cell Invasiveness and Defines a Novel Stem Cell/Metastasis-Associated Gene Signature
Am. J. Pathol., May 1, 2009; 174(5): 1650 - 1662.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Hirschfeld, A. zur Hausen, H. Bettendorf, M. Jager, and E. Stickeler
Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer
Cancer Res., March 1, 2009; 69(5): 2082 - 2090.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Jin, H. P. Kim, J. Cao, M. Zhang, E. Ifedigbo, and A. M. K. Choi
Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death
FASEB J, February 1, 2009; 23(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T.-W. Tan, W.-H. Yang, Y.-T. Lin, S.-F. Hsu, T.-M. Li, S.-T. Kao, W.-C. Chen, Y.-C. Fong, and C.-H. Tang
Cyr61 increases migration and MMP-13 expression via {alpha}v{beta}3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells
Carcinogenesis, February 1, 2009; 30(2): 258 - 268.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Monnier, P. Farmer, G. Bieler, N. Imaizumi, T. Sengstag, G. C. Alghisi, J.-C. Stehle, L. Ciarloni, S. Andrejevic-Blant, R. Moeckli, et al.
CYR61 and {alpha}V{beta}5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
Cancer Res., September 15, 2008; 68(18): 7323 - 7331.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Meyuhas, E. Pikarsky, E. Tavor, A. Klar, R. Abramovitch, J. Hochman, T. G. Lago, and A. Honigman
A Key Role for Cyclic AMP-Responsive Element Binding Protein in Hypoxia-Mediated Activation of the Angiogenesis Factor CCN1 (CYR61) in Tumor Cells
Mol. Cancer Res., September 1, 2008; 6(9): 1397 - 1409.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-T. Lin, I-H. Kuo, C.-C. Chang, C.-Y. Chu, H.-Y. Chen, B.-R. Lin, M. Sureshbabu, H.-J. Shih, and M.-L. Kuo
Involvement of Hypoxia-inducing Factor-1{alpha}-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion
J. Biol. Chem., June 6, 2008; 283(23): 15807 - 15815.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. C. Crockett, N. Schutze, D. Tosh, S. Jatzke, A. Duthie, F. Jakob, and M. J. Rogers
The Matricellular Protein CYR61 Inhibits Osteoclastogenesis by a Mechanism Independent of {alpha}v{beta}3 and {alpha}v{beta}5
Endocrinology, December 1, 2007; 148(12): 5761 - 5768.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Leask and D. J. Abraham
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
J. Cell Sci., December 1, 2006; 119(23): 4803 - 4810.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
V. Todorovicc, C.-C. Chen, N. Hay, and L. F. Lau
The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
J. Cell Biol., November 7, 2005; 171(3): 559 - 568.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Gery, D. Xie, D. Yin, H. Gabra, C. Miller, H. Wang, D. Scott, W. S. Yi, M. L. Popoviciu, J. W. Said, et al.
Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells
Clin. Cancer Res., October 15, 2005; 11(20): 7243 - 7254.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M.-T. Lin, C.-Y. Zuon, C.-C. Chang, S.-T. Chen, C.-P. Chen, B.-R. Lin, M.-Y. Wang, Y.-M. Jeng, K.-J. Chang, P.-H. Lee, et al.
Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-{kappa}B/Cyclooxygenase-2 Signaling Pathway
Clin. Cancer Res., August 15, 2005; 11(16): 5809 - 5820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yin, N. Bennani-Baiti, and C. T. Powell
Phorbol Ester-induced Apoptosis of C4-2 Cells Requires Both a Unique and a Redundant Protein Kinase C Signaling Pathway
J. Biol. Chem., February 18, 2005; 280(7): 5533 - 5541.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-M. Kim, J.-H. Park, S.-K. Chung, J.-Y. Kim, H.-Y. Hwang, K.-C. Chung, I. Jo, S.-I. Park, and J.-H. Nam
Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death
J. Virol., December 15, 2004; 78(24): 13479 - 13488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Chen, S.-J. Leu, V. Todorovic, S. C.-T. Lam, and L. F. Lau
Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells
J. Biol. Chem., October 15, 2004; 279(42): 44166 - 44176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Leu, N. Chen, C.-C. Chen, V. Todorovic, T. Bai, V. Juric, Y. Liu, G. Yan, S. C.-T. Lam, and L. F. Lau
Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61): SELECTIVE INACTIVATION OF INTEGRIN {alpha}6{beta}1-HEPARAN SULFATE PROTEOGLYCAN CORECEPTOR-MEDIATED CELLULAR FUNCTIONS
J. Biol. Chem., October 15, 2004; 279(42): 44177 - 44187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation
J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Sakamoto, M. Yokoyama, X. Zhang, K. Prakash, K. Nagao, T. Hatanaka, R. H. Getzenberg, and Y. Kakehi
Increased Expression of CYR61, an Extracellular Matrix Signaling Protein, in Human Benign Prostatic Hyperplasia and Its Regulation by Lysophosphatidic Acid
Endocrinology, June 1, 2004; 145(6): 2929 - 2940.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Endocrinology.